These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36282706)

  • 21. UBE3A reinstatement as a disease-modifying therapy for Angelman syndrome.
    Elgersma Y; Sonzogni M
    Dev Med Child Neurol; 2021 Jul; 63(7):802-807. PubMed ID: 33543479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases.
    Chaudhary P; Proulx J; Park IW
    Virus Res; 2023 Oct; 335():199191. PubMed ID: 37541588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome.
    Krzeski JC; Judson MC; Philpot BD
    Curr Opin Neurobiol; 2024 Oct; 88():102899. PubMed ID: 39126903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling.
    Furusawa K; Ishii K; Tsuji M; Tokumitsu N; Hasegawa E; Emoto K
    Science; 2023 Sep; 381(6663):1197-1205. PubMed ID: 37708280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
    Musi CA; Agrò G; Buccarello L; Camuso S; Borsello T
    Neurobiol Dis; 2020 Jul; 140():104812. PubMed ID: 32087286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UBE3A regulates the transcription of IRF, an antiviral immunity.
    Furumai R; Tamada K; Liu X; Takumi T
    Hum Mol Genet; 2019 Jun; 28(12):1947-1958. PubMed ID: 30690483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.
    Reiter LT; Seagroves TN; Bowers M; Bier E
    Hum Mol Genet; 2006 Sep; 15(18):2825-35. PubMed ID: 16905559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biallelic variants in HECT E3 paralogs, HECTD4 and UBE3C, encoding ubiquitin ligases cause neurodevelopmental disorders that overlap with Angelman syndrome.
    Faqeih EA; Alghamdi MA; Almahroos MA; Alharby E; Almuntashri M; Alshangiti AM; Clément P; Calame DG; Qebibo L; Burglen L; Doco-Fenzy M; Mastrangelo M; Torella A; Manti F; Nigro V; Alban Z; Alharbi GS; Hashmi JA; Alraddadi R; Alamri R; Mitani T; Magalie B; Coban-Akdemir Z; Geckinli BB; Pehlivan D; Romito A; Karageorgou V; Martini J; Colin E; Bonneau D; Bertoli-Avella A; Lupski JR; Pastore A; Peake RWA; Dallol A; Alfadhel M; Almontashiri NAM
    Genet Med; 2023 Feb; 25(2):100323. PubMed ID: 36401616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse models.
    Farook MF; DeCuypere M; Hyland K; Takumi T; LeDoux MS; Reiter LT
    PLoS One; 2012; 7(8):e43030. PubMed ID: 22916201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing.
    Stanurova J; Neureiter A; Hiber M; de Oliveira Kessler H; Stolp K; Goetzke R; Klein D; Bankfalvi A; Klump H; Steenpass L
    Sci Rep; 2016 Aug; 6():30792. PubMed ID: 27484051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.
    Colas D; Wagstaff J; Fort P; Salvert D; Sarda N
    Neurobiol Dis; 2005 Nov; 20(2):471-8. PubMed ID: 15921919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors.
    Tsagkaris C; Papakosta V; Miranda AV; Zacharopoulou L; Danilchenko V; Matiashova L; Dhar A
    Curr Gene Ther; 2020; 19(6):359-366. PubMed ID: 31914913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angelman syndrome protein UBE3A interacts with primary microcephaly protein ASPM, localizes to centrosomes and regulates chromosome segregation.
    Singhmar P; Kumar A
    PLoS One; 2011; 6(5):e20397. PubMed ID: 21633703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
    Sonzogni M; Zhai P; Mientjes EJ; van Woerden GM; Elgersma Y
    Mol Autism; 2020 Sep; 11(1):70. PubMed ID: 32948244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel variant in UBE3A in a family with multigenerational intellectual disability and developmental delay.
    Zhao X; Zheng Y; Wang L; Wang Y; Mei S; Kong X
    Mol Genet Genomic Med; 2022 Apr; 10(4):e1883. PubMed ID: 35225435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
    Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
    Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome.
    Ramirez J; Lectez B; Osinalde N; Sivá M; Elu N; Aloria K; Procházková M; Perez C; Martínez-Hernández J; Barrio R; Šašková KG; Arizmendi JM; Mayor U
    Hum Mol Genet; 2018 Jun; 27(11):1955-1971. PubMed ID: 29788202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
    Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
    Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
    Gustin RM; Bichell TJ; Bubser M; Daily J; Filonova I; Mrelashvili D; Deutch AY; Colbran RJ; Weeber EJ; Haas KF
    Neurobiol Dis; 2010 Sep; 39(3):283-91. PubMed ID: 20423730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of UBE3A antibodies in mice and human cerebral organoids.
    Sen D; Drobna Z; Keung AJ
    Sci Rep; 2021 Mar; 11(1):6323. PubMed ID: 33737669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.